Wednesday, August 26, 2015

Alternet Systems, Inc. (ALYI) Mastering the Rapidly Evolving Digital Currency and Mcommerce Domain

According to recent analysis by leading payments industry and digital commerce news destination Let’s Talk Payments, in its 2015 report on the state of the U.S. mcommerce market, the total value of transactions conducted via smartphones and tablets is on track to hit somewhere around $120 billion by 2017, moving on the strength of increasing mobile device proliferation that will create a consumer base of over 150 million users. Given that the baseline mcommerce market was worth around anywhere from $58 billion last year, according to data compiled from Forrester, eMarketer, FangDigital and Comscoredatamine by MartMobi, to as much as $88 billion, according to personalized retargeting company Criteo, and accounting for 27 percent of the broader $305 billion ecommerce space, mobile payment technologies like digital currency Bitcoin and mobile wallet services like Apple Pay (NASDAQ: AAPL) are now gaining increased attention.

Indeed they should, as mobile transactions on the whole grew by around 10 percent in Q4 2014 alone, and have grown to as much as 30 percent of the ecommerce space this year according to Criteo. With no signs of slowing down on the horizon, and now for the first time ever accounting for more than 50 percent of all ecommerce in markets like South Korean and Japan, mcommerce has fully emerged as a high-growth target for venture capital, which plowed $4.2 billion into the space from Q3 2013 to Q3 2014 (250 percent higher than in 2013). Globally, the portrait is even more compelling, with mcommerce taking up an ever larger slice of the now $1.6 trillion global ecommerce pie with each passing day. The U.S. mobile in-person market for NFC-based (near-field communications, or contactless payments) transactions alone was around $3.7 billion last year, and this one chunk of the mcommerce space is set to nearly double by the end of this year according to Forrester.

Cryptocurrency transaction technologies are a particularly hot segment to keep an eye on, with tremendous room for growth and a nearly $3.7 billion market cap that is currently dominated by Bitcoin ($3.135 billion). Bitcoin is really coming of age too, as the recent hard fork transition to Bitcoin XT continues taking shape. With the goal of allowing the Bitcoin network to overcome significant payment processing limitations, by increasing the block size from 1 megabyte (effectively limiting volume to seven or fewer transactions per second) and thus making the network more able to service growing demand, Bitcoin XT would help the cryptocurrency compete with payment processing networks like the one Visa uses, which can handle up to 56,000 payments per second. Perhaps more importantly, the regulatory environment has also matured substantially, with the August 10 deadline having recently passed for virtual currency business activity in the state of New York to get up to speed with the New York Department of Financial Services’ (NYDFS) June BitLicense policy stipulations.

The New York BitLicense framework heralds a new age for cryptocurrency that could soon be characterized by 49 other states adopting similar policies, which would require a formal application process and licensing fees like those in New York, substantial hurdles which have shaken out all but the sector’s most serious participants, such as leading industry wallet service Coinbase. The new licensing framework has sent several entities packing, like Hong Kong-based Bitfinex, the biggest Bitcoin exchange by dollar volume, as well as the Kraken and Poloniex exchanges, leaving the state’s market wide open to remaining players.

One of the company’s doubling down into this monumental evolution is digital currency and mcommerce services facilitator Alternet Systems, Inc. (OTC: ALYI), whose wholly owned Alternet Payment Solutions subsidiary has secured a strategic agreement with the global leader in digital currency solutions, BitPay. The agreement with BitPay centers on providing B2B payment methods for North American, Caribbean and Asia-Pacific clients who want to do things like rapidly and seamlessly convert digital currencies and fiat currencies back and forth. Alternet Systems is also continuing to aggressively pursue a New York state BitLicense and develop into one of the world’s top digital currency exchanges via the company’s wholly owned OneMarket subsidiary.

Add to these vectors Alternet Systems’ move to address the need for a comprehensive debit/credit card solution in the digital currency space, via its launch of the first U.S. based Bitcoin debit card, and you have a compelling model for success in this arena. Acting through a formal agreement with Wildcard Consulting, which will handle product development, technical integration and commercial deployment, the debit card element of Alternet Systems’ strategy is particularly interesting, given that it will be the first platform able to rapidly allow for digital and fiat currencies to be readily exchanged through already accepted mechanisms, providing a ramping strategy for immediate and ubiquitous proliferation across the retail spectrum.

Because this platform enables all vendors to accept digital currencies and get paid immediately in USD or any other currency they wish, it eliminates one of the last remaining barriers that have hindered digital currencies like Bitcoin from going supernova. The long-term implications for Alternet Payment Solutions and mcommerce are profound indeed, and investors should keep a close eye on ALYI, as it is a triple threat which is clearly serious about leaping over any and every regulatory hurdle that crops up in coming months and years, in order to secure a big slice of the mcommerce and digital currency pie for its shareholders.

Take a closer look at Alternet Systems by visiting www.alternetsystems.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.


Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Aristocrat Group Corp. (ASCC) Capitalizing on Rising Consumer Interest in Premium Spirits

The rapid rise of the craft beer industry in the United States is well documented. In 2011, craft beer sales accounted for approximately $8.7 billion, and by 2014, this figure grew to $19.6 billion, according to a report by the Brewers Association. While this market performance is certainly noteworthy, one statistic that’s remained somewhat under the radar throughout this period is the persistent rise of the premium spirits market. According to data from the Distilled Spirits Council of the United States, sales volume for spirits rose by 2.2 percent in 2014, giving the domestic spirits industry a market share victory of the beer industry for the fifth straight year.

“Consumer interest in industry innovations and premium products from distilled spirits producers of all sizes contributed to another year of steady growth in 2014,” Peter Cressy, president of the Distilled Spirits Council, stated in an interview with Fortune.

Aristocrat Group Corp. (OTCQB: ASCC), through the distribution of its ultra-premium RWB Vodka, is capitalizing on this market performance. The company’s handcrafted, American-made vodka is produced using the highest-quality Idaho potatoes and pure mountain spring water that gives it a top-shelf taste without the top-shelf price. In less than two years, RWB has received 17 tasting awards, placing it among the most highly-decorated American vodkas on the market.

On August 8, Aristocrat will celebrate the second anniversary of its flagship product, which is currently sold in more than 30 retail locations and 100 clubs, bars and restaurants around the country. Last month, the company took a major step toward building on the early market success of RWB Vodka by adding Canada to its growing distribution network. Additionally, Aristocrat announced the initiation of a marketing campaign designed to increase RWB Vodka’s brand recognition in the potentially lucrative Canadian market, providing the company with a tremendous opportunity to promote strong growth in the coming months.

“We believe our potential for growth in the Canadian marketplace is huge,” Robert Federowicz, chief executive officer of Aristocrat, stated in a news release. “RWB Vodka is one of the only spirits in the country approved for ‘gluten-free’ labeling, and that’s going to make our product stand out from the pack.”

In the fiscal quarter ending April 30, Aristocrat successfully leveraged the growing reach of its RWB Vodka distribution network to record dramatically improved financial results. In particular, the company realized a year-over-year increase in total revenue of more than 800 percent. Moving forward, Aristocrat will look to build on these results by expanding upon its established distribution network, as well as through the introduction of new and innovative products, such as its upcoming Bag-in-Box Vodka line. For prospective investors, the company’s recent performance, along with the growing market for premium distilled spirits, could provide a platform for sustainable returns in the future.

For more information, visit www.aristocratgroupcorp.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.


Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Tuesday, August 25, 2015

BioAdaptives, Inc. (BDPT) Promoting Financial Growth through Impending Nationwide Product Roll-Out

BioAdaptives, Inc. (OTC: BDPT) is engaged in the research and development of science-based nutraceutical products for human and animal consumption. By sourcing high quality raw materials, the company is able to develop innovative products designed to improve overall health and wellness by providing a collection of benefits ranging from improved cognition and focus to reduced fatigue. BioAdaptives also owns exclusive rights to a non-invasive bioelectromagnetic device that has been shown to improve the effectiveness of individual ingredients, clearing the way for higher quality products that meet the unique needs of the nutraceutical industry.

In June, BioAdaptives took a significant step toward financial growth through the announcement of a nationwide product roll-out, which is expected to take place in the third quarter of 2015. The company highlighted five products to be offered as part of this release – including PrimiCell®, a scientifically-proven stem cell activator; PrimiLive™, which provides stress-relief and energy without stimulants; PrimiTrim™, an effective natural weight management product; Equine Regen Plus™, an all-encompassing multi-faceted equine wellness product for performance horses; and Canine Regen™, an effective supplement for canine stem cell health and wellness. BioAdaptives’s development pipeline also includes additional products currently being tested, which are expected to be released later this year.

“It’s been a long and rewarding process to develop these products,” Barry Epling, chairman of BioAdaptives, stated in a news release. “We are genuinely excited about the prospects to improve the overall wellness of our customers.”

Following the release of its initial product line, BioAdaptives will be in a favorable position to capitalize on the strong performance of the global nutraceuticals market. According to a report from MarketsandMarkets, the market for nutraceutical ingredients is projected to climb to approximately $38.7 billion by 2020, realizing a compound annual growth rate of about 7.2 percent for the next five years. Moving forward, the company will look to establish itself as a leading supplier of quality nutraceutical products in a collection of developed countries with aging populations while continuing to create new and innovative products that generate growth in both sales and profitability.

With its initial product roll-out scheduled to occur by the end of the quarter, it’s an exciting time for prospective shareholders of BioAdaptives. Look for the company to continue making progress toward increasing its market share and promoting sustainable financial growth in the months to come.

For more information, visit www.bioadaptives.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

GrowBLOX Sciences, Inc. (GBLX) Names John Poss as New CFO

GrowBLOX Sciences (OTC: GBLX), a biopharmaceutical company with state-of-the-art technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, today announced John Poss as its new chief financial officer.

“First joining us as a consultant, the performance of John Poss and his impact on our company, made the hiring of him as a full-time key executive an obvious choice. This choice supports our transition from the engineering intensive development stage to the day-to-day operations of producing an excellent product, branding it appropriately, and maximizing our revenue. We feel that John will be instrumental in helping us to achieve that transition smoothly and expeditiously,” stated GrowBLOX Sciences CEO Craig Ellins. “John’s experience, in business and in life, speaks for itself.”

The company describes Poss as having “an aptitude for solving complex problems and improving performance in technology, logistics, business systems, and finance.” Poss previously served as CFO, CEO, COO, and CTO of both public and private companies with sales ranging from $10 million to $450 million as well as over 15 years of consulting experience. He also has extensive M&A experience, both buy and sell side, including private equity. His success has been demonstrated across multiple industries, including telecommunications, transportation/logistics, manufacturing, finance/mortgage, construction, mining, oil, gas, and public accounting/consulting. Additionally, he is a proven innovator with two issued patents. Further, he’s led major projects and negotiated over $1 billion in commercial agreements and dispute resolutions in 15 countries.

“I am very happy to join GrowBLOX. As a cancer survivor, I am a strong believer in the value of medical marijuana in many cases and to treat many diseases. I am excited to be a part of this revolution, which has been developing, slowly, throughout my lifetime,” stated Poss.

For more information visit http://growblox.com.

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Giggles N’ Hugs, Inc. (GIGL) Posts Q2 2015 Results, Improvements

Giggles N’ Hugs (OTC:GIGL), owner and operator of family-friendly restaurants that combine high-end, organic food with active, cutting-edge play and entertainment for children, this morning announced its financial results for the 13 weeks ended June 28, 2015.

Second-quarter 2015 net sales were $830,812, up 0.8% from net sales of $824,611 reported in the second quarter of 2014. Giggles N’ Hugs attributes the increase to the continuing trend for higher party rentals. Sales were up 3.4% for private party rentals and other sales, offsetting the higher allowances, returns and discounts. The Glendale location showed the highest increase of 5.5% over the comparable period from last year, which offset the slightly lower sales from the other locations.

Giggles N’ Hugs posted a second-quarter 2015 net loss of $474,826, a decrease of 0.5% compared to a net loss of $477,309 for the comparable quarter of 2014. Management believes losses will continue to be reduced and profitability will be attained in future quarters as the popularity of its restaurants increases.

“The recent additions to our management team, Philip Gay as chief business development officer and John Kaufman as interim-president, have brought a tremendous level of experience and leadership to Giggles N’ Hugs in the few short months they’ve been on board,” Joey Parsi, founder and CEO of Giggles N’ Hugs, stated in the news release. “Having worked together previously in their roles as CFO and COO respectively at California Pizza Kitchen, where they helped grow the chain from two locations to more than 70, they are helping us immensely as we prepare for our expansion on the West Coast and beyond.”

Parsi continued, “Together with the help of Todd Star, the former head of west coast leasing at Westfield USA who is now spearheading our negotiations with all the major mall owners in the country, we’re moving forward on our plans to open new locations in markets like Seattle and San Francisco in the north and San Diego and Orange County in the south. With the expected significant discounts from current market rents as well as attractive tenant allowances that have been offered, we should see great reductions in construction costs and rent for the new locations.

“We also continue to receive substantial interest from large multi-unit franchising operators and small individual franchisees, both domestically and internationally. This is an area that represents immense growth potential for Giggles N’ Hugs, and will provide very attractive margins, and complements our core company-owned expansion plans. With John and Philip’s extensive experience in the franchising space, with John serving as president of Koo Koo Roo Chicken and Philip serving as CFO at California Pizza Kitchen, and interim CEO at Wolfgang Puck Foods, I believe this will be an area that brings solid improvements to shareholder value as we execute. With what I consider to be an all-star management team we now have in place, we are very excited about what the future holds for Giggles N Hugs.”

For more information, visit www.gigglesnhugs.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Dominovas Energy Corporation (DNRG) Issues Update on Business Trip to Sub-Saharan Africa

Dominovas Energy (OTC: DNRG), an Atlanta-based energy-solutions company, today issued details of its sub-Saharan Africa tour of South Africa, Democratic Republic of the Congo (DRC), and Mozambique. Dominovas Energy senior executives are meeting with public and private sector leaders, off-takers, country managers and other operating partners in coordination and planning for both existing and prospective deployments of the company’s proprietary RUBICON™ systems. During the tour, Dominovas Energy executives have also met with Power Africa financial institution partners.

VIEW PHOTOS: http://DTN.fm/DRC-Meeting

“This trip has been a phenomenal success, in that we have experienced first-hand the benefits of being a Power Africa partner, by connecting with other Power Africa partners,” Eric Fresh, Dominovas Energy’s SVP of Finance and Investments, stated in the news release. “These are dynamic financing environments for power and infrastructure projects in sub-Saharan Africa. We are incredibly impressed with how engaged and motivated these sources of capital are in support of the deployment of clean, reliable and sustainable power generation assets, like our RUBICON™ system.”

The company noted that beyond engaging with the financing community, the trip has enabled Dominovas Energy to engage principal stakeholders for its projects based in the DRC, as well as other prospective projects in various stages of the sales cycle.

“The Dominovas Energy team has been pleasantly surprised and is appreciative of the tremendous reception we received when we arrived in Johannesburg last week to meet with officials. We knew the momentum would continue through this week in the DRC, as these activities are a culmination of the relationships we have organically cultivated, as well as those which have been further enhanced as a Power Africa partner,” said Michael Watkins, COO and president of the Fuel Cell Division. “As anticipated, we have expanded the overall interest and enthusiasm for the RUBICON™ as an impactful and clean energy solution, further solidifying our market stronghold and commitment in Africa.”

“This week, we will complete our summer African tour in South Africa, Mozambique and the DRC … the DRC, of course, is where we have over 200MW of signed and executed guaranteed PPAs,” stated Emilio De Jesus, president of the Africa Division of Dominovas Energy. “To keep the 200MW in proper context, once deployed, the RUBICON™ will produce more than 1.7 million MW-hours of fuel cell generated power for the country, enough to supply power to over 200,000 homes. Equally important, the conversation and dialogue we have advanced with strategic project financing partners brings us precipitously closer to securing the type of financing required to ensure we deliver on the broader Power Africa goals of adding 60 million new electricity connections and generating 30,000 megawatts of new and cleaner power.”

For more information, visit www.dominovasenergy.com.

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Monday, August 24, 2015

MIT Holding (MITD) Identifies Industry Transition to Value-Based & Ambulatory Care; Moves to Profitability as a Result

The continued growth of the ambulatory (outpatient) care market is driven by a number of emergent factors. The increase in life spans have incubated a prevalence of diseases such as diabetes and COPD (chronic obstructive pulmonary disease) among an increasingly elderly population of retiring Baby Boomers. Insurance carriers are now authorizing payments for more services that that result in more affordable convenience and logistical efficacy of home-based recuperation for these patients, with cost savings of up to 65 percent for minimally invasive procedures when performed at home or in an ambulatory care center. However, it is extremely difficult for already overburdened families to successfully arrange and utilize a comprehensive suite of services, such as home-based infusions, access to durable medical equipment (DME), and the benefits of a comprehensive prescription drug program administrated by a pharmacy benefit manager, by a single healthcare provider (PBM).

MIT Holding Inc. (OTC: MITD) has identified this niche and filled it successfully. Moreover, all participants in the ambulatory care market, whether patients, medical facilities or insurance carriers, benefit directly from tight-knit relationships and the kind of well-oiled networking machinery that MIT Holding offers its patients.

This is particularly important as the industry continues rapidly transitioning from Meaningful Use Stage 1 requirements to the much more complex criteria of Stage 2, where robust clinical reporting that is in-line with regulatory and quality-driven initiatives, as well as coordinated care and patient engagement, are paramount. When it comes to Medicare and Medicaid EHR (electronic health record) Incentive Program participation, healthcare information technology (HCIT) continues to open new doors for the ambulatory care market, and this segment of the overall healthcare market stands to deliver optimum results when it comes to the prevailing value-based care initiatives as well. Patient long-term outcomes and customer service are more of a key focus in ambulatory care than in acute hospital care, and this is a major driving factor of the industry’s continued shift toward ambulatory care.

Organized as a single source provider for a wide range of services and products to patients through its network of affiliates and contractors, MIT Holding is able to hit the sweet spot between cost effective care and customer service. The company delivers intravenous infusions for home and ambulatory care center injection via its full service compounding pharmacy, as well as pharmaceuticals, medical equipment for the home, and other home-based healthcare. The typical high cost of specialized infusion pharmacy services can be substantially ameliorated through ambulatory care, and the kind of customized education/counseling that is also required to get the patient situated regarding their condition and the requisite treatments, is ideally deliverable via the ambulatory care model (again in clear contrast with hospital care).

Saving the patient time and money is also a highly lucrative niche market for MIT Holding, as infusion medications typically require preparation by highly specialized pharmacy operations employing registered pharmacists, and the therapy itself is generally administered by a registered nurse or trained caregiver that ideally has established a good, long-term relationship with the patient.

A growing number of therapies are now deliverable in this fashion as well, making in-home treatment increasingly attractive to patients, and the option of going to a contracted ambulatory care center (the company operates one itself), staffed with full-time nurses and a doctor, in order to receive improved consultation, or assistance in obtaining reimbursement, is seen as a huge advantage to many patients and their families.

This is a big, growing market for MIT Holding, spanning such infusion therapies as total parenteral nutrition for chronic digestive and gastro-intestinal disorders, anti-ineffective therapies for diseases like chronic urinary tract infections, chronic pain management through intravenous or continuous analgesics, and a variety of others. In this same vein, the company’s DME sales and leasing capabilities, with access to a host of devices ranging from wheelchairs and oxygen concentrators, to nebulizers and other sustained-use equipment, provides MIT Holding with a constantly growing amount of Medicaid billing.

The expansion last year of the DME contract by WellPoint’s (NYSE: WLP) Georgia subsidiary, Amerigroup Community Care, to cover all of MIT Holding’s services (including ambulatory, infusion and perinatal), is a prime example of the company’s continually growing post-acute network footprint. Similarly, two contracts awarded more recently by HCIT and post-acute treatment patient transition innovator Curaspan Health Group, which maintains an impressive 98 percent customer retention rate, gave the company real-time access to market its compound pharmaceuticals, infusion services and DME offerings to the patients of over 5,400 Curaspan driven medical facilities nationwide.

The company’s deal with Coastal Carolina Medical Center is another good example here, in that the in-patient treatments MIT Holding was initially engaged to do dovetail exceptionally well with subsequent, more expansive ambulatory care service provisions, generating billing in the $1,000 per treatment range for the company.

With current approval by more than 130 insurance carriers for a variety of medical goods and services, as well as a much more focused core of operations specifically in the home health recovery space, MIT Holding has seriously tightened up its cost and revenue structure subsequent to its reorganization that began in 2011, and currently enjoys a 32 percent net profit standard on sales, services, and the like moving forward. Estimates of up to 90 percent savings for patients who utilize in-home infusion services will continue to be a major contributor to the company’s success, and with the U.S. home infusion market on track to grow 68 percent over the next five years to around $26.7 billion, MIT Holding will be looking to carve an ever-increasing slice of that pie off for its shareholders in years to come.

A continued focus on providing affordable, customer service-driven delivery of high-cost, low volume specialty infusions spells big profit for MIT Holding, and the requisite handling/administration requirements associated with such infusions will help the company maintain a firm grasp on the underlying market’s dynamics. And because MIT Holding handles all its own billing and collection practices via a sophisticated computerized billing framework, obtaining the lion’s share of its revenues from contracts with third party payers, affiliates and contractors, as well as self-pay patients and self-insured employers, the company has unprecedented fluidity when it comes to the claim review and editing process, as well as granular pre-service initiation control driven by rigorous insurance coverage verification and carrier authorization protocols.

For more information visit http://mitholdinginc.com/

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net